(Reuters) - Medical device maker Boston Scientific Corp said it expects to grow faster than the overall market for implantable heart devices, which has been struggling in recent years amid weak worldwide demand. Full story
(Reuters) - Boston Scientific Corp <BSX.N> reported weaker quarterly earnings on Tuesday as sales slipped and expenses rose, and the medical device maker announced more job cuts. Full story
CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a prominent cardiologist wrote in an editorial of a top medical journal. Full story
(Reuters) - Boston Scientific Corp said on Thursday it will acquire privately-held Vessix Vascular Inc, a developer of a catheter-based device that treats high blood pressure by deadening nerves near the kidneys. Full story
(Reuters) - Medical device maker Boston Scientific Corp said it would buy privately held heart device maker BridgePoint Medical Inc to gain access to its product that restores blood flow in blocked coronary arteries. Full story
WASHINGTON (Reuters) - Boston Scientific Corp won a round in a legal battle with Medtronic Inc on Tuesday over an implantable medical device called a CRT, which gives the heart electrical jolts if it fails to pump blood properly. Full story
